Your browser is no longer supported. Please, upgrade your browser.
Settings
NXTM Nxstage Medical, Inc. daily Stock Chart
NXTM [NASD]
Nxstage Medical, Inc.
Index- P/E- EPS (ttm)-0.12 Insider Own0.80% Shs Outstand64.56M Perf Week0.83%
Market Cap1.58B Forward P/E1743.57 EPS next Y0.01 Insider Trans-7.58% Shs Float63.09M Perf Month5.44%
Income-7.40M PEG- EPS next Q-0.04 Inst Own97.40% Short Float7.18% Perf Quarter17.92%
Sales357.70M P/S4.41 EPS this Y37.60% Inst Trans3.11% Short Ratio8.42 Perf Half Y63.17%
Book/sh3.04 P/B8.03 EPS next Y108.30% ROA-2.40% Target Price27.86 Perf Year45.73%
Cash/sh0.91 P/C26.94 EPS next 5Y20.00% ROE-3.80% 52W Range13.49 - 26.07 Perf YTD11.41%
Dividend- P/FCF477.55 EPS past 5Y11.10% ROI-8.00% 52W High-5.60% Beta0.42
Dividend %- Quick Ratio2.10 Sales past 5Y13.40% Gross Margin40.70% 52W Low82.43% ATR0.58
Employees3600 Current Ratio3.00 Sales Q/Q14.80% Oper. Margin-1.70% RSI (14)61.80 Volatility1.94% 2.52%
OptionableYes Debt/Eq0.02 EPS Q/Q68.10% Profit Margin-2.10% Rel Volume0.89 Prev Close24.41
ShortableYes LT Debt/Eq0.01 EarningsNov 03 BMO Payout- Avg Volume538.19K Price24.61
Recom1.70 SMA203.90% SMA504.74% SMA20027.03% Volume363,290 Change0.82%
Jun-28-16Upgrade Northland Capital Market Perform → Outperform
Mar-31-16Resumed Piper Jaffray Overweight $23 → $18.50
Dec-11-15Initiated Sterne Agee CRT Buy
May-03-13Reiterated Feltl & Co. Hold $11.50 → $12
Mar-01-13Reiterated Feltl & Co. Hold $13 → $11.50
Dec-04-12Downgrade Northland Securities Outperform → Market Perform
Sep-07-12Initiated Northland Securities Outperform $18
Feb-18-11Reiterated Rodman & Renshaw Mkt Underperform $15 → $18
Dec-03-10Initiated Jefferies Buy $27
Oct-14-10Downgrade Rodman & Renshaw Mkt Perform → Mkt Underperform $15
Sep-15-10Initiated Feltl & Co. Buy $19
Jul-26-10Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
May-06-10Reiterated Rodman & Renshaw Mkt Outperform $11 → $14
Jan-08-10Initiated Rodman & Renshaw Mkt Outperform $11
Jun-05-09Upgrade William Blair Mkt Perform → Outperform
Aug-06-08Reiterated SMH Capital Buy $8 → $7
Aug-06-08Reiterated Canaccord Adams Hold $7 → $4.75
Jul-29-08Initiated SMH Capital Buy $8
May-14-08Reiterated JMP Securities Mkt Outperform $13 → $10
May-13-08Downgrade William Blair Outperform → Mkt Perform
Sep-13-16 11:47AM  NxStage Medical, Inc. Value Analysis (NASDAQ:NXTM) : September 13, 2016
Sep-12-16 08:47AM  NxStage Medical, Inc. breached its 50 day moving average in a Bearish Manner : NXTM-US : September 12, 2016
Aug-29-16 11:53AM  ETFs with exposure to NxStage Medical, Inc. : August 29, 2016
Aug-12-16 01:04PM  NXSTAGE MEDICAL, INC. Financials
Aug-08-16 08:00AM  NxStage Launches First of Many NxGen Features and Capabilities PR Newswire
Aug-05-16 10:43AM  NxStage Medical, Inc. :NXTM-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016
Aug-04-16 06:50PM  Edited Transcript of NXTM earnings conference call or presentation 4-Aug-16 1:00pm GMT +8.31%
08:59AM  NxStage reports 2Q loss
08:17AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh
08:06AM  NxStage Reports Second Quarter Financial Results And Raises Full-Year Revenue Guidance PR Newswire
07:07AM  Q2 2016 NxStage Medical Inc Earnings Release - Before Market Open
Aug-03-16 10:56AM  Medical Product Stock Earnings on Aug 4: NXTM, AGIO & More
Aug-02-16 08:00AM  NxStage to Present at Canaccord Genuity 36th Annual Growth Conference PR Newswire
Jul-21-16 08:00AM  Macon Dialysis Center Grand Opening PR Newswire
Jul-19-16 04:32PM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Jul-18-16 09:17AM  Bet on These 5 Profitable Stocks to Boost Your Returns
Jul-13-16 08:30AM  Boston Scientific's Restructuring Plan & Innovation Offer Hope
Jul-12-16 08:17PM  FDA Okays Medtronic's NuVent for Expanded Use in Sinusitis
Jul-08-16 10:27AM  Illumina Stock Hit by Downbeat Guidance, Stiff Competition
08:54AM  Halyard Health Now a Strong Buy, Portfolio Key Catalyst
Jul-01-16 08:30AM  NxStage® to Report Second Quarter 2016 Financial Results PR Newswire
Jun-28-16 09:26AM  Nxstage Medical upgraded by Northland Capital +6.37%
Jun-27-16 05:01PM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Jun-22-16 07:57AM  Nextcom Ltd. (Israel) :NXTM-IL: Earnings Analysis: Q1, 2016 By the Numbers : June 22, 2016
Jun-13-16 05:26PM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
Jun-09-16 08:40AM  Nxstage Medical (NXTM) Catches Eye: Stock Jumps 5.6%
Jun-02-16 03:28PM  Nextcom Ltd. (Israel) :NXTM-IL: Earnings Analysis: 2015 By the Numbers : June 2, 2016
Jun-01-16 04:31PM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-24-16 08:00AM  NxStage Announces Second Quarter 2016 Investor Conference Schedule PR Newswire
May-10-16 07:30AM  8 Stocks Spiking on Big Volume at TheStreet
May-05-16 12:32PM  NxStage Medical, Inc. :NXTM-US: Earnings Analysis: Q1, 2016 By the Numbers
May-04-16 04:51PM  Edited Transcript of NXTM earnings conference call or presentation 4-May-16 1:00pm GMT
11:43AM  NxStage Medical Cuts Its Losses as Critical Care Leads Sales Higher at Motley Fool
09:00AM  NxStage Medical Inc Earnings Call scheduled for 9:00 am ET today
08:25AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh
08:20AM  NxStage reports 1Q loss
08:05AM  NxStage Reports First Quarter Financial Results PR Newswire
07:07AM  Q1 2016 NxStage Medical Inc Earnings Release - Before Market Open CCBN
Apr-25-16 08:00AM  NxStage to Present at the Deutsche Bank 41st Annual Health Care Conference PR Newswire
Apr-18-16 05:33PM  NxStage Medical, Inc. Value Analysis (NASDAQ:NXTM) : April 18, 2016
05:12PM  ETFs with exposure to NxStage Medical, Inc. : April 18, 2016
Apr-15-16 10:45AM  IHI Remained Flat, Hovering Around Its 52-Week High
08:04AM  NxStage Medical, Inc. breached its 50 day moving average in a Bullish Manner : NXTM-US : April 15, 2016
Apr-12-16 08:00AM  NxStage Kidney Care Opens New Dialysis Centers in Baltimore, Maryland PR Newswire
Apr-07-16 08:00AM  National Donate Life Month: NxStage Teams Up with Organ Donation Nonprofit MatchingDonors.com PR Newswire
Mar-18-16 02:37PM  How Has Medical Device ETF IHI Performed? +7.45%
Mar-02-16 08:00AM  NxStage Celebrates Third Annual National Home Hemodialysis Day on March 3rd PR Newswire
Mar-01-16 12:59PM  The Stock Picks of This Obscure Hedge Fund Returned 70.5% In 2015; See What Its Betting On in 2016 at Insider Monkey
Feb-24-16 08:00AM  NxStage Presents New Findings on Lowering HHD Attrition Through Nx2me Connected Health Technology and Increased Training Volume PR Newswire
Feb-13-16 10:15AM  4 BioPharma Movers That Cannot Be Ignored at 24/7 Wall St.
Feb-11-16 12:30PM  Nxstage Q4 Loss in Line with Estimates, Revenues Up Y/Y
10:02AM  NxStage Medical, Inc. Earnings Analysis: 2015 By the Numbers
08:29AM  NXSTAGE MEDICAL, INC. Files SEC form 10-K, Annual Report
Feb-10-16 04:48PM  Why NxStage Medical, Inc. Guided Lower Today at Motley Fool -14.20%
03:54PM  Edited Transcript of NXTM earnings conference call or presentation 10-Feb-16 2:00pm GMT
12:18PM  NxStage Medical Grows but Expects No Profit for 2016 at Motley Fool
08:20AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh
08:19AM  NxStage reports 4Q loss
08:01AM  NxStage Reports Record Fourth Quarter and Full-Year 2015 Revenue PR Newswire
07:07AM  Q4 2015 NxStage Medical Inc Earnings Release - Before Market Open
Feb-05-16 08:30AM  Qualitative Analysis Highlights These Top Stocks -- Steris, Wright Medical Group, Nxstage Medical, and NuVasive Accesswire -6.05%
Feb-03-16 08:00AM  NxStage Announces First Quarter 2016 Investor Conference Schedule PR Newswire
Jan-19-16 08:00AM  NxStage® to Report Fourth Quarter and Full Year 2015 Financial Results PR Newswire
Jan-13-16 11:00AM  NxStage System One Use Continues in Haiti Six Years After Earthquake PR Newswire
Jan-12-16 03:00PM  Home dialysis option comes to Memphis at bizjournals.com
08:04AM  NxStage Medical, Inc. breached its 50 day moving average in a Bearish Manner : January 12, 2016
Jan-08-16 09:20AM  AngioDynamics Q2 Earnings In Line, Sales Top; '16 View Cut
Jan-07-16 02:15PM  CVS Health: '16 View Raised, Reimbursement Pressure Prevails
11:15AM  Walgreens Boots Beats Q1 Earnings; Rite Aid Deal on Track
08:00AM  NxStage Kidney Care Opens Dialysis Center in Memphis, Tennessee PR Newswire
Jan-06-16 02:00PM  Ecolab Announces Deconsolidation of Venezuelan Operations
Jan-05-16 02:30PM  Cepheid's GeneXpert System to be Distributed by Henry Schein
Dec-31-15 10:10AM  Hill-Rom's Welch Allyn Buy to Boost Growth, Margins Weak
09:30AM  Nxstage Medical (NXTM) Hits 52-Week High: Time to Buy?
Dec-29-15 08:05AM  Equities Lead Investor Sentiment - Analyst Notes on InvenSense, Northern Oil, NxStage Medical and China Ceramics Co Accesswire
Dec-28-15 12:30PM  Boston Scientific: Emerging Markets Impress, Currency Bothers
Dec-24-15 03:06PM  Fluidigm Mutes the Performance of IHIs Small Caps
Dec-23-15 02:10PM  At the Top of IHI, NxStage Extends Its Rally
Dec-22-15 05:32PM  Market Zooms, Alibaba Among 5 Breakouts & Setups
Dec-21-15 02:30PM  Zimmer Biomet: Portfolio Expansion Strong, Revenues Stumble
Dec-11-15 02:22PM  A Look at Top Picks of This Billion-Dollar Healthcare-Focused Fund at Insider Monkey
07:50AM  Where Investors Are Going - New Research on NxStage, Clean Energy Fuels, Ultratech and Merit Medical Accesswire
Dec-10-15 11:40AM  NxStage Medical, Inc. Earnings Analysis: Q3, 2015 By the Numbers
Dec-07-15 07:05AM  IHIs Small Caps Outperformed the Market
Dec-04-15 08:39AM  Should Nxstage Medical (NXTM) Be On Your Radar Now?
Dec-02-15 03:30PM  NxStage Medical, Inc. (NXTM): Are Hedge Funds Right About This Stock? at Insider Monkey
Dec-01-15 01:16PM  NxStage (NXTM) CEO -- We're 'at the Cusp' of Profitability at TheStreet
12:20PM  NxStage Medical Building Momentum After Q3 Surprise Says CEO at TheStreet
Nov-28-15 10:50AM  Here is What Hedge Funds Think About California Resources Corporation. (CRC) at Insider Monkey
Nov-27-15 01:10PM  Thermo Fisher Is Prepped to Break Out (Plus: NXTM, JACK, ESRX, NVDA)
01:00PM  NxStage Medical (NXTM) Stock Has Room to Grow at TheStreet
12:30PM  NxStage Medical Has Room to Grow (Plus: JACK, ESRX, NVDA)
11:30AM  Mead Johnson: Currency Mars Q3 Growth in Emerging Markets
11:15AM  Put JACK Back in the Box (Plus: ESRX, NVDA)
Nov-25-15 12:16PM  Is Summit Hotel Properties Inc (INN) Going to Burn These Hedge Funds? at Insider Monkey
09:00AM  Veeva (VEEV) Q3 Earnings Miss; Rise Y/Y on Revenue Strength
Nov-24-15 10:04AM  Patterson Companies Misses on Q2 Earnings; Sales Up Y/Y
Nov-23-15 08:00AM  NxStage To Present at the 27th Annual Piper Jaffray Healthcare Conference PR Newswire
Nov-19-15 02:30PM  Medtronic Buys Scotland-based Aircraft Medical for $110 M
02:20PM  Zimmer Biomet: Combined Synergy Strong, Currency Woes Stay
NxStage Medical, Inc., a medical technology company, develops, manufactures, and markets products and services for patients suffering from chronic or acute kidney failure. Its primary product includes the System One, a portable hemodialysis system, which is used primarily for home hemodialysis and a range of dialysis therapies to deliver in the home setting. The company operates through three segments: System One, In-Center, and Services. The System One segment sells and rents the NxStage System One and PureFlow SL dialysate preparation equipment, as well as sells disposable products in the home market for the treatment of end-stage renal disease (ESRD) patients in the home or a home-like setting and in the critical care market for the treatment of hospital-based patients with acute kidney failure or fluid overload. The In-Center segment engages in the sale of blood tubing sets and needles for hemodialysis primarily for the treatment of ESRD patients at dialysis centers, and needles for apheresis. The Services segment offers dialysis services to patients at NxStage Kidney Care dialysis centers. NxStage Medical, Inc. markets its products through direct sales and distributors to hospitals and dialysis centers in the United States and internationally. The company was formerly known as QB Medical, Inc. and changed its name to NxStage Medical, Inc. NxStage Medical, Inc. was founded in 1998 and is headquartered in Lawrence, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MOORE CRAIG WDirectorSep 14Sale23.601,50035,40089,239Sep 14 05:14 PM
MOORE CRAIG WDirectorSep 12Sale23.021,50034,53090,739Sep 14 05:14 PM
Giannini Daniel ADirectorAug 04Option Exercise14.9915,272228,92779,245Aug 08 04:14 PM
LEWIS EARL RDirectorMay 25Option Exercise18.5514,000259,70089,125May 27 05:21 PM
Giannini Daniel ADirectorMay 25Option Exercise18.5514,000259,70077,780May 27 05:14 PM
MOORE CRAIG WDirectorMay 25Option Exercise18.5514,000259,700106,046May 27 05:00 PM
REID PERPERDirectorMay 25Option Exercise18.557,000129,850127,483May 27 04:42 PM
Turk Joseph E JrPresidentMay 12Sale17.891,50026,835103,280May 12 04:49 PM
Turk Joseph E JrPresidentMay 10Option Exercise9.961,05710,528105,837May 11 06:14 PM
Turk Joseph E JrPresidentMay 10Sale18.001,05719,026104,780May 11 06:14 PM
Swan Winifred LSVP and General CounselApr 14Option Exercise9.966196,16514,473Apr 15 05:35 PM
Swan Winifred LSVP and General CounselApr 14Sale14.952,50037,37511,973Apr 15 05:35 PM
Turk Joseph E JrPresidentApr 05Option Exercise9.961,0009,960109,280Apr 06 04:56 PM
Turk Joseph E JrPresidentApr 05Sale15.052,50037,625106,780Apr 06 04:56 PM
Turk Joseph E JrPresidentMar 22Sale14.342,00028,680108,280Mar 23 04:21 PM
Swan Winifred LSVP and General CounselMar 14Option Exercise9.966206,17518,234Mar 15 04:49 PM
Swan Winifred LSVP and General CounselMar 14Sale15.696209,72817,614Mar 15 04:49 PM
Swan Winifred LSVP and General CounselMar 14Sale15.691,88029,49713,854Apr 15 05:35 PM
Turk Joseph E JrPresidentMar 10Option Exercise9.961,0009,960112,780Mar 10 04:28 PM
Turk Joseph E JrPresidentMar 10Sale15.582,50038,950110,280Mar 10 04:28 PM
Turk Joseph E JrPresidentMar 03Option Exercise0.009,7460114,909Mar 07 04:35 PM
Swan Winifred LSVP and General CounselMar 03Option Exercise0.007,919020,358Mar 07 04:35 PM
Burbank Jeffrey HChief Executive OfficerMar 03Option Exercise0.0028,0210921,762Mar 07 04:28 PM
Brown Robert S.President, NxStage Kidney CareMar 03Option Exercise0.009,746069,523Mar 07 04:14 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeMar 03Option Exercise0.009,746022,693Mar 07 04:07 PM
Turk Joseph E JrPresidentFeb 24Option Exercise2.119922,093108,155Feb 25 04:07 PM
Straube Barry MDirectorFeb 24Buy14.201,50021,3001,500Feb 25 04:07 PM
Turk Joseph E JrPresidentFeb 24Sale14.122,99242,247105,163Feb 25 04:07 PM
Swan Winifred LSVP and General CounselFeb 16Option Exercise9.966206,17514,939Feb 18 04:21 PM
Swan Winifred LSVP and General CounselFeb 16Sale14.072,50035,17512,439Feb 18 04:21 PM
LEWIS EARL RDirectorFeb 12Buy14.6321,000307,16088,145Feb 17 07:35 AM
Turk Joseph E JrPresidentFeb 09Option Exercise9.961,0009,960109,663Feb 10 04:56 PM
Turk Joseph E JrPresidentFeb 09Sale16.882,50042,200107,163Feb 10 04:56 PM
Turk Joseph E JrPresidentFeb 04Option Exercise2.119912,091109,654Feb 05 04:07 PM
Turk Joseph E JrPresidentFeb 04Sale19.6099119,424108,663Feb 05 04:07 PM
Turk Joseph E JrPresidentJan 20Sale18.752,00037,500108,663Jan 21 04:21 PM
Swan Winifred LSVP and General CounselJan 14Option Exercise9.966206,17514,939Jan 15 04:07 PM
Swan Winifred LSVP and General CounselJan 14Sale19.041,88035,79515,734Apr 15 05:35 PM
Swan Winifred LSVP and General CounselJan 14Sale19.0462011,80514,319Jan 15 04:07 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeJan 11Option Exercise14.053,47248,78216,419Jan 11 04:21 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeJan 11Sale20.403,47270,82912,947Jan 11 04:21 PM
Turk Joseph E JrPresidentJan 08Option Exercise11.031,50016,545112,163Jan 11 04:21 PM
Turk Joseph E JrPresidentJan 08Sale21.031,50031,545110,663Jan 11 04:21 PM
Turk Joseph E JrPresidentJan 07Option Exercise9.962,21322,041114,376Jan 08 04:42 PM
Turk Joseph E JrPresidentJan 07Sale20.783,71377,156110,663Jan 08 04:42 PM
Turk Joseph E JrPresidentDec 31Option Exercise7.7211,20086,432112,163Jan 04 04:21 PM
Turk Joseph E JrPresidentDec 22Option Exercise11.033,00033,090105,963Dec 23 04:07 PM
Turk Joseph E JrPresidentDec 22Sale20.925,000104,600100,963Dec 23 04:07 PM
Turk Joseph E JrPresidentDec 16Option Exercise9.968007,968103,763Dec 17 04:21 PM
Turk Joseph E JrPresidentDec 16Sale19.9980015,992102,963Dec 17 04:21 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeDec 15Option Exercise14.052,86340,22515,810Dec 17 04:21 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeDec 15Sale19.512,86355,85712,947Dec 17 04:21 PM
Swan Winifred LSVP and General CounselDec 14Option Exercise9.966206,17516,819Dec 15 04:21 PM
Swan Winifred LSVP and General CounselDec 14Sale18.902,50047,25014,319Dec 15 04:21 PM
Burbank Jeffrey HChief Executive OfficerDec 10Option Exercise2.119,27419,568886,030Dec 11 04:35 PM
Burbank Jeffrey HChief Executive OfficerDec 10Sale18.949,274175,650876,756Dec 11 04:35 PM
Turk Joseph E JrPresidentDec 08Option Exercise9.961,41314,073105,876Dec 09 05:21 PM
Turk Joseph E JrPresidentDec 08Sale19.382,91356,454102,963Dec 09 05:21 PM
MOORE CRAIG WDirectorNov 20Sale20.001,00020,00092,046Nov 20 06:35 PM
Turk Joseph E JrPresidentNov 19Sale19.652,00039,300104,463Nov 20 06:28 PM
LEWIS EARL RDirectorNov 18Sale19.7618,020356,07575,125Apr 15 05:49 PM
MOORE CRAIG WDirectorNov 18Sale19.604,00078,40093,046Nov 18 06:28 PM
Swan Winifred LSVP and General CounselNov 16Option Exercise9.966206,17518,699Nov 17 05:07 PM
Swan Winifred LSVP and General CounselNov 16Sale19.652,50049,12516,199Nov 17 05:07 PM
Turk Joseph E JrPresidentNov 12Option Exercise8.912,55522,763110,518Nov 16 05:49 PM
Turk Joseph E JrPresidentNov 12Sale20.444,05582,884106,463Nov 16 05:49 PM
Burbank Jeffrey HChief Executive OfficerNov 10Option Exercise2.1110,00021,100886,756Nov 12 09:07 PM
REID PERPERDirectorNov 10Option Exercise18.557,000129,850126,763Nov 12 08:56 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeNov 10Option Exercise14.052,86340,22515,810Nov 12 09:14 PM
Turk Joseph E JrPresidentNov 10Option Exercise11.037,50082,725115,463Nov 12 09:21 PM
Turk Joseph E JrPresidentNov 10Sale21.037,500157,725107,963Nov 12 09:21 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeNov 10Sale20.322,86358,17612,947Nov 12 09:14 PM
Burbank Jeffrey HChief Executive OfficerNov 10Sale20.7510,000207,500876,756Nov 12 09:07 PM
Giannini Daniel ADirectorNov 09Sale20.306,593133,83863,780Nov 10 08:14 PM
Turk Joseph E JrPresidentNov 04Option Exercise9.964,00039,840111,963Nov 05 05:07 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeNov 04Option Exercise14.058,591120,70421,538Nov 04 05:49 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeNov 04Sale19.508,591167,52512,947Nov 04 05:49 PM
Turk Joseph E JrPresidentNov 04Sale19.964,00079,840107,963Nov 05 05:07 PM
Turk Joseph E JrPresidentNov 03Option Exercise9.968268,227108,789Nov 05 05:07 PM
Brown Robert S.President, NxStage Kidney CareNov 03Option Exercise9.9644,400442,224104,177Nov 04 06:00 PM
Brown Robert S.President, NxStage Kidney CareNov 03Sale19.0044,400843,60059,777Nov 04 06:00 PM
Turk Joseph E JrPresidentNov 03Sale18.0082614,868107,963Nov 05 05:07 PM
Turk Joseph E JrPresidentOct 20Sale15.802,00031,600107,963Oct 22 06:14 PM
Burbank Jeffrey HChief Executive OfficerOct 16Option Exercise2.1110,00021,100886,756Oct 16 05:28 PM
Burbank Jeffrey HChief Executive OfficerOct 16Sale15.5910,000155,900876,756Oct 16 05:28 PM
Burbank Jeffrey HChief Executive OfficerOct 15Option Exercise2.1110,00021,100886,756Oct 15 06:21 PM
Burbank Jeffrey HChief Executive OfficerOct 15Sale14.9810,000149,800876,756Oct 15 06:21 PM
Swan Winifred LSVP and General CounselOct 14Option Exercise9.966206,17520,579Oct 14 05:49 PM
Swan Winifred LSVP and General CounselOct 14Sale15.462,50038,65018,079Oct 14 05:49 PM
Turk Joseph E JrPresidentOct 08Option Exercise7.971,33910,675107,002Oct 09 04:42 PM
Turk Joseph E JrPresidentOct 08Sale15.422,83943,777104,163Oct 09 04:42 PM